Skip to main content

Antitumor and antioxidant effects of Clinacanthus nutans Lindau in 4 T1 tumor-bearing mice



Clinacanthus nutans Lindau (C. nutans) is a species of in Acanthaceae family and primarily used in South East Asian countries. C. nutans is well known as Sabah snake grass in Malaysia, and its leaves have diverse medicinal potential in conventional applications, including cancer treatments. On the basis of literature search, there is less conclusive evidence of the involvement of phytochemical constituents in breast cancer, in particular, animal tumor models. The current study aimed to determine the antitumor and antioxidant activities of C. nutans extract in 4 T1 tumor-bearing mice.


C. nutans leaves were subjected to methanol extraction and divided into two different concentrations, 200 mg/kg (low-dose) and 1000 mg/kg (high-dose). The antitumor effects of C. nutans extracts were assessed using bone marrow smearing, clonogenic, and splenocyte immunotype analyses. In addition, hematoxylin and eosin, tumor weight and tumor volume profiles also used to indicate apoptosis appearance. Serum cytokine levels were examined using ELISA assay. In addition, nitric oxide assay reflecting antioxidant activity was performed.


From the results obtained, the methanol extract of C. nutans leaves at 200 mg/kg (P < 0.05) and 1000 mg/kg (P < 0.05) showed a significant decrease in nitric oxide (NO) and malondialdehyde (MDA) levels in the blood. On the other hand, C. nutans extract (1000 mg/kg) also showed a significant decrease in the number of mitotic cells, tumor weight, and tumor volume. No inflammatory and adverse reactions related to splenocytes activities were found in all treated groups of mice. Despite its promising results, the concentration of both C. nutans extracts have also reduced the number of colonies formed in the liver and lungs.


In conclusion, C. nutans extracts exert antitumor and antioxidant activities against 4 T1 mouse breast model with no adverse effect and inflammatory response at high dose of 1000 mg/kg, indicating an effective and complementary approach for cancer prevention and treatment.

Peer Review reports


Cancer is the uncontrolled development of abnormal cells that distinguish between benign and malignant tumors in which colon and breast cancer cases are among prevalent cancers diagnosed in humans. In Malaysia, the Ministry of Health (MOH) has reported that the mortality rate due to cancer cases has increased by approximately 10–11% throughout in 2016 [1]. The increased in the number of cancer cases has led to early death worldwide. The most common types of cancer treatment are surgery, hormonal therapy, chemotherapy, and radiation therapy. Beside modern treatments, herbal medicine uses plants or mixtures of plant extracts to treat diseases and promote health, since they contain various medicinal phytochemicals [2]. The natural sources have been recognized for tropical centuries and as an alternative and complementary approach to cancer treatments with minimal cost and side effects [3]. Medicinal plants with anticancer and antioxidant properties are Annona muricata Linn [4], Andrographis paniculata [5], Gynura sarmentosa [6], Centella asiatica [7], and Clinacanthus nutans [8, 9].

Clinacanthus nutans Lindau (C. nutans) is a species of the Acanthaceae family and traditionally known as Sabah Snake Grass in Malaysia. The plant has numerous therapeutic potentials in modern and traditional herbal medicine such as anti-diabetic [10], anti-inflammatory [11], anti-microbial [12], anti-viral [13], skin rashes and gout [14]. Many different parts of C. nutans are useful for cancer treatments such as aerials, seeds, flower, leaves and stems. Nevertheless, most of the previous studies used the plant leaves using various extraction protocols such as alcoholic, chloroform, petroleum and methanolic. The leaves are flat, opposite and narrowly elliptical-oblong, containing terpenoids and phenolic compounds [15]. C. nutans extracts have been used for the treatments of various types of carcinomas including colon cells, breast cells and brain cells [14, 16]. Ng et al. have also reported that C. nutans water extract induces human oral squamous cell apoptosis [17]. Despite claims regarding its antioxidant and anticancer capacity, several specifics yet to be examined, especially in animal models. Therefore, the present study was intended to determine the antitumor and antioxidant potentials of methanol extract of C. nutans in breast cancer cell line in vivo.


Chemicals and reagents

Murine mammary carcinoma cell line, 4 T1 cells and RPMI-1640 were purchased from American Type Culture Collection (ATCC). Griess Reagent Kit was purchased from Molecular Probes, Eugene, OR. DuoSet ELISA Development System was purchased from R&D Systems, USA.

Plant materials

Clinacanthus nutans Lindau (C. nutans) was collected from TKC Herbal Nursery Sdn Bhd, Negeri Sembilan, Malaysia, and was classified as the whole plant of C. nutans by a science officer named Mr. Lim Chung Lu from the Phytomedicinal Herbarium at Institute of Bioscience (IBS), UPM before the sample was deposited in our laboratory (Voucher No. SK2775/15).

Preparation of extract

The C. nutans leaves were harvested freshly. After the leaves have been thoroughly dried, the leaves were then ground into powder form and sequentially soaked in methanol at room temperature. The extract was then filtered using Whatman42 filter paper. The filtrate was oven-dried at 37 °C and then kept at 20 °C until further analysis.

Cell culture

Murine mammary carcinoma cell line, 4 T1 cells were purchased from the American Type Culture Collection (ATCC, USA) and were maintained in RPMI-1640 medium supplemented with 1% penicillin-streptomycin, 1 mM sodium pyruvate, 2 mM glutamine and 10% FBS. Cells were placed in a CO2 incubator with 95% humidity at 37 °C.


Six to eight-week-old female BALB/c mice were purchased from the Animal House of Faculty of Veterinary Medicine, Universiti Putra Malaysia. The mice were kept under a condition of 12-h dark/light cycle at 25 °C. The mice were fed with standard pellet diet and distilled water ad libitum. All the procedures involving mice were carried out in compliance with the regulations of the Animal Care and Use Committee (ACUC; UPM/IACUC/AUP-R086/2017), Universiti Putra Malaysia.

Tumor inoculation and treatments

Mice were divided into 4 groups (n = 7), which consisted 1) control (without breast cancer, untreated), 2) untreated (with breast cancer, untreated) and two other groups of mice harboring breast cancer treated with 200 mg/kg (low-dose) and 1000 mg/kg (high-dose) of C. nutans extract. Similar doses were reported with normal behavior in a study by Lau et al., [18]. In this animal model, 1 × 106 4 T1 cells were subcutaneously inoculated, and 10 days of incubation were given for tumor growth prior to initiation of treatment. All treatments were administrated daily by oral gavage for 28 days. The size of tumors was measured using a vernier caliper with following the formula, V = (W x W x L)/2 where V is volume, W is width and L is length. After 28 days, mice were euthanized by cervical dislocation. Blood, tumors and vital organs such as liver, lung, spleen, bone marrow were collected for the following analyses. The weight of the tumors was recorded as well.

Immunotyping of Splenocytes

After mice euthanasia, the spleen was aseptically collected and excised for isolation of splenocytes for immunophenotyping as defined in the previous study [19]. Briefly, the spleen was prepared into single-cell suspension with Hank’s Balance Salt Solution (HBSS) containing 5 mM HEPES and 10% FBS by meshing with a 70 μm strainer. The splenocytes were incubated in lysis buffer (0.1 mM EDTA, 10 mM KHCO3, 0.15 M NH4Cl at pH 7.5) for 10 min at 4 °C for the removal of red blood cells. The cells were then rinsed with PBS before staining with appropriate antibodies (Abcam, USA) at 37 °C for 3 h. Next, the cells were rinsed with PBS twice before fixed with 1% paraformaldehyde (PFA). The cells were kept in the dark at 4 °C until analyzing through FACSCalibur flow cytometer (BD, USA).

Clonogenic assay of lung and liver

The procedure has already been identified and carried out with minor modifications [20]. Briefly, the lung and liver were harvested and then cut into small fragments in sterile condition. The fragments were incubated in 5 ml enzyme cocktail containing 1X PBS, 1 mg/ml of hyaluronidase and 1 mg/ml of type I collagenase for 30 min at 37 °C. After incubation, the cell-containing solution was passed through a 70 mm cell strainer. The cells were pelleted down and washed with PBS twice. The cells were resuspended in 10 ml selection medium and incubated for 7 to 10 days at 37 °C, 5% CO2, and 95% humidity. After incubation, the plate was prepared with fixing of methanol and stained with crystal violet to count the number of colonies formed per organ.

Bone marrow smearing

Bone marrow smears were prepared from the contents of the right femur, as previously described [21]. Briefly, bone marrows were flushed with 1X PBS and smeared across a clean glass slide. The slide was dried in air at room temperature prior to fixation with 100% methanol for 30 min and air-dried again before staining. The slide was then stained with Giemsa stain for 10 min and then air-dry.

Hematoxylin and eosin staining (H&E)

Formalin-fixed paraffin-embedded sections of the tumor tissues were carried out as described in our previous study [22]. Briefly, the tumors were harvested and fixed in 10% neutral buffered formalin before being sent to the Histopathology Laboratory, Faculty of Veterinary Medicine, Universiti Putra Malaysia for hematoxylin and eosin staining. The stained tissue sections of 0.45 μm were examined under a microscope (Nikon).

Nitric oxide (NO) radical scavenging assay

The level of nitric oxide production was detected using the modified Griess assay [23]. Briefly, a mixture of 20 μl Griess reagent, 150 μl nitrite-containing sample and 130 μl distilled water were prepared. On the other side, a photometric reference sample was prepared by mixing 20 μl of Griess reagent and 280 μl of distilled water. The nitrite solutions were prepared by diluting the standard solution with distilled water. The absorbance of generic nitrite solutions was then measured in order to plot a standard curve of nitrite concentration against absorbance. The concentrations of nitrite corresponding nitrite concentrations corresponding to the absorbance of the samples were read from the standard plot.

Malondialdehyde (MDA) assay

For quantification of MDA level, this procedure was adapted from the procedure by Samiaa et al., [24]. A mixture of 200 μl sample, 800 μl of PBS, 25 μl of butylated hydroxytoluene (BTH) and 500 μl of trichloroacetic acid (TCA) was prepared in a 50 ml tube and incubated on ice for 2 h. After incubation, the tube was centrifuged for 15 min at room temperature prior to mixing 1 ml of the supernatant with 75 μl of 0.1 M EDTA and 250 μl of thiobarbituric acid (TBA) in 1 M NaOH. The mixture was boiled for 15 min and cooled down to room temperature. The absorbance was measured at 532 nm and 600 nm using a spectrophotometer (Beckman Coulter, USA).

Cytokines ELISA assay

The level of IL-2 and Interferon-γ (IFN-γ) secretions were assessed from the serum mice. The samples were collected and analysed using the DuoSet ELISA Development System (R&D Systems, USA). Designated capture antibodies (Mouse IL-2 Capture Antibody and IFN-γ Capture Antibody) were diluted to working concentration in PBS without carrier protein. The procedures were performed in accordance with the manufactural protocol. Briefly, 96-well plates were coated with 100 μl per well of the diluted Capture Antibodies and incubated overnight at room temperature. The following day, the plates were washed three times with Wash Buffer. The plates were then blocked with Block buffer at room temperature for 1 h. Next, 100 μl of serum in Reagent Diluent was added in each well and incubated for 2 h. The solutions were aspirated, washed three times and added 100 μl of detection antibodies were applied. The plates were then incubated for another 2 h. Next, each well was incubated with Streptavidin-HRP at room temperature for 20 min. The plates were washed three times before incubation with Substrate Solution for 20 min. Lastly, the reaction was stopped by adding Stop Solution and the plates were read at 450 nm and 570 nm using a microplate reader (Azure Biosystems).

Statistical analysis

All data presented in the standard error of the mean (SEM) and performed using the SPSS version17. Data were analyzed using one-way ANOVA, followed by Dunnett’s multiple comparisons test. P < 0.05 was considered to be significant.


Tumor growth and tumor weight

After 28 days of treatment, the high-dose of methanol extract of C. nutans significantly reduced the volume and weight of the tumor in mice. The weight of tumors was reduced in the low-dose group (1.396 ± 0.251 g) and high-dose group (1.338 ± 0.327 g) compared to the untreated group (1.565 ± 0.357 g) as rendered in Fig. 1a. Similarly, in Fig. 1b, the volume of tumors in the untreated group was 391.0 ± 26.7 mm3, whereas in the low-dose of treatment group, the weight decreased to 370.1 ± 24.9 mm3. Tumor volume also significantly decreased from 391.0 ± 26.7 mm3 to 302.2 ± 40.3 mm3 in the high-dose of C. nutans–treated group.

Fig. 1

The weight and volume of tumors from untreated and C. nutans–treated groups. a Weight of tumors was measured after being harvested on 28 days of post-treatment. b Volume of tumors was measured using a Vernier caliper. Each value represents the mean ± standard error of the mean. Significance is set at *P < 0.05

C. nutans affects immune cell populations

Several antibodies for immune system marker antibodies (CD3, CD4, CD8, and NK1.1) were used to identify the C. nutans activity on splenocyte cell populations. As rendered in Fig. 2, the population of CD4/CD3 and CD8/CD3 cells was found to increase significantly, independent of low-dose and high-dose of C. nutans treatments compared to the untreated group. There was also a similar pattern in the NK1.1/CD3 population in low-dose and high-dose treatments relative to the untreated group even not significantly different. To further refine the anti-metastatic effect of C. nutans, the secretion of cytokines (IL-2 and IFN-γ) were measured, as conferred with Fig. 3. The expression levels of IL-2 and IFN-γ have increased in both low-dose and high-dose of C. nutans treatments compared to the untreated group. As rendered in Fig. 3, the expression level of IL-2 was fewer in the untreated group (471.1 ± 46.3 pg/ml) compared to low-dose and high-dose of C. nutans groups were 508.9 ± 34.2 pg/ml and 525.7 ± 28.5 pg/ml, respectively. In addition, the level of IFN-γ in the untreated group (187.2 ± 3.24 pg/ml) was decreased to 209.7 ± 12.3 pg/ml and 352.4 ± 24.9 pg/ml in the low-dose- and high-dose-treated mice.

Fig. 2

Flow cytometry analysis of immune markers (CD4, CD8, CD3 and NK 1.1) on the splenocytes of the untreated mice, treated mice with low- and high-dose of methanol C. nutans extract. The percentage of the CD4/CD3 T-cell and CD8/CD3 T-cell population was increased significantly for both low and high-dose of treatment when compared to the untreated and control groups. The population of natural killer (NK) 1.1/CD3 cells was also increased in both low and high-dose of C. nutans treatment when compared to untreated and control groups

Fig. 3

Enzyme-linked immunosorbent assay analysis on the detection of the level of in IL-2 and IFN-γ in serum of the untreated group, treated mice with low and high-dose of C. nutans extract. The levels of expression for both IL-2 and IFN-γ have increased for both low and high C. nutans treatment when compared with the untreated group. Each value represents the mean ± standard error of the mean. Significance is set at *P < 0.05

C. nutans regulates inflammation and antioxidant activity

To elucidate the inflammation effect of C. nutans in the tumors, the level of nitrite oxide (NO) was measured. The level of NO was decreased in both low-dose and high-dose of C. nutans treatment groups compared to the untreated group. As presented in Fig. 4, the expression level of NO was decreased from 0.080 ± 0.025 μM/mg in the untreated group to 0.054 ± 0.013 μM/mg in low-dose of treatment and 0.044 ± 0.010 μM/mg in high-dose of C. nutans treatment. To determine the antioxidant properties of C. nutans methanol extract, while, the level of MDA was also elucidated. As shown in Fig. 5, the MDA level in the untreated group was 0.017 ± 0.001 nM/mg, whereas in the low-dose and high-dose of C. nutans treatments were 0.013 ± 0.001 nM/mg and 0.0083 ± 0.001 nM/mg, respectively.

Fig. 4

Level of nitric oxide assay from the untreated and treated groups (low-dose and high-dose of C. nutans). Each value represents the mean ± standard error of the mean. Significance is set at *P < 0.05. The level of NO decreased significantly in low-dose and high-dose of treatment compared to the untreated group

Fig. 5

Level of MDA from the untreated and treated groups (low-dose and high-dose of C. nutans). Each value represents the mean ± standard error of the mean. Significance is set at *P < 0.05. The level of MDA decreased significantly in low-dose and high-dose of treatment compared to the untreated group

C. nutans possesses an anti-metastatic effect in vivo

To determine the anti-metastatic activity of the C. nutans in vivo, the tumor sections were stained with hematoxylin and eosin (H&E). As rendered in Fig. 6, abnormal mitotic figures and coarse chromatin data were seen more visible and frequently in the untreated group compared to the low-dose and high-dose of treatment. In addition, the number of mitotic cells decreased in both the low-dose and high-dose of treatment as shown in Fig. 6b. On the other hand, the clonogenic assay was established to elucidate the anti-metastatic properties of C. nutans further. As shown in Fig. 7, the number of colonies produced in the liver and lung with a low-dose of treatment was significantly decreased while no colonies were formed at a high-dose of treatment. The presence of large and irregular cells was reported as metastatic cells in the bone marrow assay as shown in Fig. 8 which has been found only in the untreated group.

Fig. 6

Histology analysis of the untreated, low-dose and high-dose of C. nutans. a Both tumor samples of the untreated and treated groups are stained with hematoxylin and eosin (H&E). (b) The number of mitotic cells decreased significantly in low-dose and high-dose of C. nutans treatment compared to the untreated group. Notes: a Circles represent cells undergoing mitosis. Magnification: 40X. Significance is set at *P < 0.05

Fig. 7

Clonogenic assay of mice organs. a Representative images of colonies formed in the lung and liver organs. b Bar chart of the total 4 T1 colonies formed from the mashed lung and liver harvested from the untreated, treated mice with low-dose and high-dose of C. nutans treatment after 10 days of incubation. Notes: a Lung, dilution factor: 103; liver, dilution factor: 103. b Each value represents mean ± standard error of the mean; *P < 0.05

Fig. 8

Bone marrow cells stained with Giemsa viewed under a phase-contrast microscope. Notes: Circles indicate the presence of abnormal cells base on the different morphology. Magnification: 40X


Previous studies have reported that the C. nutans extracts possess anticancer and antioxidant properties in various cancer cell lines in vitro; nevertheless, their antioxidant and antitumor activities have not been completely elucidated in murine models [25,26,27]. Therefore, our experiments have shown that the methanolic extract of C. nutans leaves could inhibit the tumor progression in 4 T1 tumor-bearing mice model. Mean weight and tumor size were significantly reduced after 28-days of C. nutans treatments. These findings were showed as typical phenotypic features of apoptosis, and similar patterns were also reported the inhibitory benefits using water and petroleum ether protocols [28, 29]. In response to DNA damage, a typical appearance of actively mitotic cells in C. nutans-treated tumors was decreased compared to control and untreated groups (H&E profiles). Hence, targeted inhibition of tumors would generally affect only active mitotic cells [30]. Taken together, these results suggested that the progression of 4 T1 tumors hindered by apoptosis response.

Immune-mediated responses in malignancy are unique and diverse, such that the interfering of immune cell populations at different stages of tumor progression might be affected by the tumor aggressiveness [31]. Since T-cells are a pivotal player in the tumor microenvironment, promoting their function might have adverse effects on solid tumors. It was evident that the C. nutans extract increased several types of NK1.1 cell and T-cell populations. The percentages of CD3, CD8, and NK1.1 cells have increased in the C. nutans-treated groups (low and high-doses) compared to the untreated group. Both T-cells and NK cells activity contribute to the eliminating of tumor cells by inducing cell lyses. The cytotoxic T-cells (CD4 and CD8 cells) and NK cells played a critical role in the surveillance and characterized their elimination of target cells [32, 33]. Thus, increasing of the activities of immune cells such as CD3, CD4, CD8, and NK1.1 thereby confer increased the phytochemical constituents efficacy, resulting in impaired tumor metastasis and progression. Furthermore, increased CD3 and CD8 cells are also associated with improved cancer survival rates.

Several studies suggest that cytokines also play significant roles in the regulating of immune cells [34, 35]. For instance, IL-2 is necessary for T-cell activation and contributes to its clinical benefits, such as in controlling the survival of immature and mature T cells [36]. Therefore, the increased IL-2 secretion may contribute to the capacity of T cells activity, thus boosting the immune system. Furthermore, the level of IFN-γ secretion also increased in the C. nutans-treated mice. As a consequence, the activation of NK cells and CD8 cells with stimulation of other cytokines (IL-2 and IFN-γ) have contributed to synergy impact on the inhibition of tumor cells. Cytokines involved in cancer-related inflammation represent a potential target and innovative diagnosis for clinicians and scientists. A previous study showed that IL-6 has the ability to induce apoptosis in many human ovarian cancer developments by blocking the IL-6R/STAT3 pathway [37].

The correlation between inflammation and cancer in the tumor microenvironment has been extensively studied. Indeed, inflammation can promote oncogene activation leading to tumor initiation, tumor progression and metastatic dissemination in the body [38, 39]. Nitric oxide (NO) is one of the short-lived signaling molecules which act as an intercellular messenger in various immune and inflammatory conditions [40]. C. nutans treatments result in the decline of NO levels in both the low-dose and high-dose groups. The results of the NO were consistent with malondialdehyde (MDA) levels in the tumor tissues. The MDA levels within the tumors are reduced when treated with C. nutans due to its antioxidant properties. Similarly, the antioxidant effect in hepatoma cells was also exhibited by decreasing the MDA levels. According to the findings, it could be advocated that C. nutans may protect cancer cells from apoptosis signals and facilitate the survival of tumor cells [41, 42]. It also protects healthy cells and their cellular mechanism from the damage caused by unstable molecules known as free radicals [43].

Tumor angiogenesis is a new development of blood capillaries/vessels which tumor cells can migrate in the blood or lymphatic system and circulate through the intravascular during metastatic progression. The versatile platform may provide a chance of cancer cells to spread and develop in new areas distant from their primary tumors [44]. The inhibition of tumor angiogenesis and inflammation-related markers by C. nutans have reflected the reduction of the number of colonies established in the liver and lung. Therefore, the finding showed that the C. nutans extracts have effectively inhibited the metastatic potential of the 4 T1 tumor-bearing mice. In addition, the findings of bone marrow smearing have also shown that no appearance of atypical or erratic cells were found in the C. nutans-treated mice.


In conclusion, the methanol extract of C. nutans leaves even in low-dose (200 mg/kg) contains antitumor and antioxidant constituents that are capable of scavenging free radicals and inhibiting the growth of tumor progression. These findings also indicate that the phytochemical constituents present in methanol extract could be used as an alternative and complimentary for cancer prevention and treatment. However, more extensive studies are needed to characterize the bioactive constituents of the C. nutans extract and to understand the underlying mechanism of antitumor activity in order to unveil its potential use in cancer therapy.

Availability of data and materials

The datasets analyzed during the current study are available from the corresponding author on reasonable request.



Fetal bovine serum


Hematoxylin and eosin


Interferon gamma








Signal transducer and activator of transcription 3


  1. 1.

    Mahmud A, Aljunid SM. Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: a preliminary study using travel impedance approach. PLoS One. 2018;13(2):e0191764.

    Article  Google Scholar 

  2. 2.

    Wu YX, Fang X. Apigenin, chrysin, and luteolin selectively inhibit chymotrypsin-like and trypsin-like proteasome catalytic activities in tumor cells. Planta Med. 2010;76:128–32.

    CAS  Article  Google Scholar 

  3. 3.

    Hsiao WLW, Liu L. The role of traditional Chinese herbal medicines in cancer therapy from TCM theory to mechanistic insights. Planta Med. 2010;76:1118–31.

    CAS  Article  Google Scholar 

  4. 4.

    Syed Najmuddin SUF, Alitheen NB, Hamid M, Nik Abd Rahman NMA. Comparative study of antioxidant level and activity from leaf extracts of Annona muricata linn obtained from different locations. Pertanika J Trop Agric Sci. 2017;40:119–30.

    Google Scholar 

  5. 5.

    Al-Henhena N, Ying RPY, Ismail S, Najm W, Khalifa SAM, El-Seedi H, et al. Chemopreventive efficacy of Andrographis paniculata on azoxymethane-induced aberrant colon crypt foci in vivo. PLoS One. 2014;9(11):e111118.

    Article  Google Scholar 

  6. 6.

    Jarikasem S, Charuwichitratana S, Siritantikorn S, Chantratita W, Iskander M, Frahm AW, et al. Antiherpetic effects of Gynura procumbens. Evidence-based Complement Altern Med. 2013;394865.

  7. 7.

    Hussin F, Eshkoor SA, Rahmat A, Othman F, Akim A. The centella asiatica juice effects on DNA damage, apoptosis and gene expression in hepatocellular carcinoma (HCC). BMC Complement Altern Med. 2014;14(32):1–7.

    Google Scholar 

  8. 8.

    Yong YK, Tan JJ, Teh SS, Mah SH, Ee GCL, Chiong HS, et al. Clinacanthus nutans extracts are antioxidant with antiproliferative effect on cultured human cancer cell lines. Evidence-based Complement Altern Med. 2013;462751.

  9. 9.

    Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, et al. Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res. 2011:6083–96.

  10. 10.

    Vidyalakshmi A, Ananthi S. Induction of Andrographolide , A Biologically Active Ingredient in Callus of Andrographis paniculata ( Burm . F ). Bioeng Biosci 2013;1:1–4.

  11. 11.

    Mai CW, Yap KSI, Kho MT, Ismail NH, Yusoff K, Shaari K, et al. Mechanisms underlying the anti-inflammatory effects of Clinacanthus nutans Lindau extracts: inhibition of cytokine production and toll-like receptor-4 activation. Front Pharmacol. 2016;7:7.

    Article  Google Scholar 

  12. 12.

    Arullappan S, Rajamanickam P, Thevar N, Kodimani CC. In vitro screening of cytotoxic, antimicrobial and antioxidant activities of Clinacanthus nutans (Acanthaceae) leaf extracts. Trop J Pharm Res. 2014;13:1455–61.

    Article  Google Scholar 

  13. 13.

    Haetrakul T, Dunbar SG, Chansue N. Antiviral activities of Clinacanthus nutans (Burm.F.) Lindau extract against cyprinid herpesvirus 3 in koi (Cyprinus carpio koi). J Fish Dis. 2018;41:581–7.

    CAS  Article  Google Scholar 

  14. 14.

    Alam A, Ferdosh S, Ghafoor K, Hakim A, Juraimi AS, Khatib A, et al. Clinacanthus nutans: a review of the medicinal uses, pharmacology and phytochemistry. Asian Pac J Trop Med. 2016;9:402–9.

    CAS  Article  Google Scholar 

  15. 15.

    Zulkipli IN, Rajabalaya R, Idris A, Sulaiman NA, David SR. Clinacanthus nutans: a review on ethnomedicinal uses, chemical constituents and pharmacological properties. Pharm Biol. 2017;55:1093–113.

    CAS  Article  Google Scholar 

  16. 16.

    Abdul Rahim MH, Zakaria ZA, Mohd Sani MH, Omar MH, Yakob Y, Cheema MS, et al. Methanolic extract of clinacanthus nutans exerts antinociceptive activity via the opioid/nitric oxide-mediated, but cGMP-independent, pathways. Evidence-based Complement Altern Med. 2016:1–11.

  17. 17.

    Ng CT, Fong LY, Tan JJ, Rajab NF, Abas F, Shaari K, et al. Water extract of Clinacanthus nutans leaves exhibits in vitro, ex vivo and in vivo anti-angiogenic activities in endothelial cell via suppression of cell proliferation. BMC Complement Altern Med. 2018;18(5):491.

    Google Scholar 

  18. 18.

    Lau KW, Lee SK, Chin JH. Effect of the methanol leaves extract of Clinacanthus nutans on the activity of acetylcholinesterase in male mice. J Acute Dis. 2014;3:22–5.

    Article  Google Scholar 

  19. 19.

    Zamberi NR, Abu N, Mohamed NE, Nordin N, Keong YS, Beh BK, et al. The Antimetastatic and Antiangiogenesis effects of kefir water on murine breast Cancer cells. Integr Cancer Ther. 2016;15:NP53–66.

    CAS  Article  Google Scholar 

  20. 20.

    Romli F, Abu N, Khorshid FA, Syed Najmuddin SUF, Keong YS, Mohamad NE, et al. The growth inhibitory potential and Antimetastatic effect of camel urine on breast Cancer cells in vitro and in vivo. Integr Cancer Ther. 2017;16:540–55.

    Article  Google Scholar 

  21. 21.

    Xu L, Guo F, Song S, Zhang G, Liu Y, Xie X. Trastuzumab monotherapy for bone marrow metastasis of breast cancer: a case report. Oncol Lett. 2014;7:1951–3.

    Article  Google Scholar 

  22. 22.

    Ismail R, Allaudin ZN, Abdullah R, Mohd Lila MA, Nik Abd Rahman NMA, Abdul Rahman SO. Combination of VP3 and CD147-knockdown enhance apoptosis and tumor growth delay index in colorectal tumor allograft. BMC Cancer. 2016;16:461.

    Article  Google Scholar 

  23. 23.

    Syed Najmuddin SUF, Romli MF, Hamid M, Alitheen NB, Abd Rahman NMAN. Anti-cancer effect of Annona Muricata Linn leaves crude extract (AMCE) on breast cancer cell line. BMC Complement Altern Med. 2016;16:311.

    Article  Google Scholar 

  24. 24.

    AbdulwahidKurdi S, Goh Y, Ebrahimi M, Hashim Z. Effects of methanolic leaf extract of Clinacanthus nutans on body weight and fatty acid composition in male obese mice. Natl J Physiol Pharm Pharmacol. 2019;1:33–42.

    Google Scholar 

  25. 25.

    Yakop F, Abd Ghafar SA, Yong YK, Saiful Yazan L, Mohamad Hanafiah R, Lim V, et al. Silver nanoparticles Clinacanthus Nutans leaves extract induced apoptosis towards oral squamous cell carcinoma cell lines. Artif Cells Nanomed Biotechnol. 2018;46:131–9.

    CAS  Article  Google Scholar 

  26. 26.

    Teoh PL, Cheng AYF, Liau M, Lem FF, Kaling GP, Chua FN, et al. Chemical composition and cytotoxic properties of Clinacanthus nutans root extracts. Pharm Biol. 2017;55:394–401.

    CAS  Article  Google Scholar 

  27. 27.

    Baharuddin N, Morad, Rasidek N. Pressurized hot water extraction of phenolic and antioxidant activity of Clinacanthus nutan leaves using accelerated solvent extractor. J Aust Basic. 2017;11:56–63.

    CAS  Google Scholar 

  28. 28.

    Kosai P, Sirisidthi K, Jiraungkoorskul W. Evaluation of total phenolic compound and cytotoxic activity of clinacanthus nutans. Indian J Pharm Sci. 2016;78:283–6.

    CAS  Article  Google Scholar 

  29. 29.

    Raya KB, Ahmad SH, Farhana SF, Mohammad M, Tajidin NE, Parvez A. Changes in phytochemical contents in different parts of clinacanthus nutans (Burm. f.) Lindau due to storage duration. Bragantia. 2015;74:445–52.

    Article  Google Scholar 

  30. 30.

    Chan KS, Koh CG, Li HY. Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis. 2012;3(10):e411.

    Article  Google Scholar 

  31. 31.

    Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, et al. Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol. 2017;43:74–89.

    CAS  Article  Google Scholar 

  32. 32.

    Hagland HR, Lea D, Watson MM, Søreide K. Correlation of blood T-cells to intratumoural density and location of CD3+ and CD8+ T-cells in colorectal cancer. Anticancer Res. 2017;37:675–84.

    CAS  Article  Google Scholar 

  33. 33.

    Takeuchi A, Saito T. CD4 CTL, a cytotoxic subset of CD4+ T cells, their differentiation and function. Front Immunol. 2017;8:194.

    Article  Google Scholar 

  34. 34.

    Sun L, He C, Nair L, Yeung J, Egwuagu CE. Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine. 2015;75:249–55.

    CAS  Article  Google Scholar 

  35. 35.

    Huang D, Guo W, Gao J, Chen J, Olatunji JO. Clinacanthus nutans (Burm. F.) Lindau ethanol extract inhibits hepatoma in mice through upregulation of the immune response. Molecules. 2015;20:17405–28.

    CAS  Article  Google Scholar 

  36. 36.

    Duque GA, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491.

    Google Scholar 

  37. 37.

    Aryappalli P, Al-Qubaisi SS, Attoub S, George JA, Arafat K, Ramadi KB, et al. The IL-6/STAT3 signaling pathway is an early target of manuka honey-induced suppression of human breast cancer cells. Front Oncol. 2017;7:167.

    Article  Google Scholar 

  38. 38.

    Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–37.

    CAS  Article  Google Scholar 

  39. 39.

    Ruzila I, Zeenathul NA, Nik-Mohd-Afizan NAR, Sheikh-Omar AR, Norhidayah M, Mohd-Azmi ML. Tissue distribution of intramuscularly and intratumouraly administered DNA plasmid harbouring apoptotic gene in mice. Afr J Pharm Pharmacol. 2010;4:775–82.

    CAS  Google Scholar 

  40. 40.

    Akan Z, Garip AI. Antioxidants may protect cancer cells from apoptosis signals and enhance cell viability. Asian Pac J Cancer Prev. 2013;14:4611–4.

    Article  Google Scholar 

  41. 41.

    Ng PY, Chye SM, Ng CH, Koh RY, Tiong YL, Pui LP, et al. Clinacanthus nutans hexane extracts induce apoptosis through a caspase-dependent pathway in human cancer cell lines. Asian Pac J Cancer Prev. 2017;18:917–26.

    PubMed  PubMed Central  Google Scholar 

  42. 42.

    Nik-Mohd-Afizan NAR, Zeenathul NA, Noordin MM, Ruzila I, NorHidayah M, Mohd-Azmi ML. Apoptosis and tumour cell death in response to pro-apoptotic gene. Pertanika J Trop Agric Sci. 2011;34:163–6.

    Google Scholar 

  43. 43.

    Thongrakard V, Tencomnao T. Modulatory effects of Thai medicinal plant extract on proinflammatory cytokines-induced apoptosis in human keratinocyte HaCat cells. Afr J Biotechnol. 2010;9:4999–5003.

    Google Scholar 

  44. 44.

    Abdullah JM, Ahmad F, Ku Ahmad KA, Ghazali MM, Jaafar H, Ideris A, et al. Molecular genetic analysis of BAX and cyclin D1 genes in patients with malignant glioma. Neurol Res. 2007;29:239–42.

    CAS  Article  Google Scholar 

Download references


The authors would like to thank Ms. Rosmawati Jaaper for her support and assistance in this study.


This study was supported by the Fundamental Research Grant Scheme (02–02-13-1251FR; FRGS) under the Ministry of Higher Education, Malaysia for research consumables and laboratories facilities. The funding body did not involve in the design of the study, data collection, analysis, interpretation of data, as well as in writing the manuscript.

Author information




NMANAR, MAO, MH and MAML participated in the design research; NMANAR and MAML guided the group of researchers; NMY and NNAMNF carried out the experiments including in plant collection, identification and extraction. The data were analysed under supervision of NMANAR. NMANAR, NMY and NNAMNF wrote the manuscript; MAO, MH and MAML critically reviewed the manuscript. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Nik Mohd Afizan Nik Abd Rahman.

Ethics declarations

Ethics approval and consent to participate

The experimental protocol was established, performed in accordance with the guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC), Universiti Putra Malaysia (UPM/IACUC/AUP-R086/2017).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nik Abd Rahman, N.M.A., Nurliyana, M.Y., Afiqah, M.N.F.N.N. et al. Antitumor and antioxidant effects of Clinacanthus nutans Lindau in 4 T1 tumor-bearing mice. BMC Complement Altern Med 19, 340 (2019).

Download citation


  • Antitumor
  • Antioxidant
  • Clinacanthus nutans Lindau
  • Breast tumor